Scientists at the University of East Anglia (UEA) have discovered what they believe to be an Achilles heel in the defensive barrier which surrounds drug-resistant bacterial cells. [ + ]

Alchemia (ASX:ACL) has commenced recruitment for a clinical trial evaluating the use of HA-Irinotecan in combination with cetuximab in metastatic colorectal cancer. [ + ]

LBT Innovations (ASX:LBT) has raised $1.5m through a private placement - and will seek another $1.5m in a share purchase plan - to help fund trials of its Automated Plate Assessment System. [ + ]

Patrys (ASX:PAB) has been awarded a third US patent covering its cancer treatment candidate PAT-SM6, which is in clinical trials as a treatment for multiple myeloma. [ + ]

The AusBiotech 2014 national conference will feature a student poster display in the main exhibition hall for the duration of the conference, and the national winner of the AbbVie Student Poster Awards. [ + ]

Algae that survive in environments with very low light use quantum mechanics to change the shape of a protein during photosynthesis and proposedly improve their energy uptake. [ + ]

Scientists from Murdoch University have developed a theory of evolution that explains what Charles Darwin described as an "abominable mystery" - the rapid rise of flowering plants. [ + ]

World leaders in telomere research recently gathered in Sydney for the Short Telomere Syndrome Conference to share knowledge and work towards forming an international consortium to progress the understanding of telomeres and associated diseases. [ + ]

RMIT University has announced a $1.25 million research facility to support the development of cheap, ultraprecise and easy-to-use nanodevices for the rapid diagnosis and detection of health hazards. [ + ]

AusBiotech has submitted to the Competition Policy Review (June 2014) that Australia needs to complement the R&D Tax Incentive with the Australian Innovation and Manufacturing (AIM) Incentive if it is to remain competitive and relevant on the world stage. [ + ]

Osprey Medical (ASX:OSP) has secured FDA 510(k) approval for the improved version of its AVERT system, designed to reduce the risk of kidney damage from the dyes used in heart procedures. [ + ]

Researchers at the Vienna University of Technology have taken a technique for measuring the chemical composition of liquids and implemented it in a tiny sensor. [ + ]

CogState (ASX:CGS) has won a contract worth $1.9m for its Precision Recruitment tool, which enables home pre-screening for clinical trials in which cognitive impairment is a factor. [ + ]

Orthocell has presented results of a successful pilot trial of regenerative therapy Ortho-ATI in 12 patients with gluteal tendinopathy. [ + ]

GI Dynamics (ASX:GID) has presented more research into the effectiveness of - and mechanism of action behind - EndoBarrier, its non-surgical device therapy for obesity and type 2 diabetes. [ + ]